Cargando…
Evidence of Reelin Signaling in GBM and Its Derived Cancer Stem Cells
Glioblastoma (GBM) is the most aggressive and malignant form of primary brain cancer, characterized by an overall survival time ranging from 12 to 18 months. Despite the progress in the clinical treatment and the growing number of experimental data aimed at investigating the molecular bases of GBM d...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227261/ https://www.ncbi.nlm.nih.gov/pubmed/34205192 http://dx.doi.org/10.3390/brainsci11060745 |